GET A DEMO

Preclinical Document Automation

We transform your complex study data into clear, regulatory-compliant documents

Yseop Copilot's automation packs automate the critical chain of preclinical documents to deliver a comprehensive level of report automation for highly accurate narratives.

Purpose-Built for Preclinical Scientific Writing Requirements

Immediate value for Biotechs & CROs

With a simple, no code interface, Yseop Copilot supports preclinical scientific writing requirements

High quality first drafts of reports & comprehensive automation coverage

Hybrid AI methodology combines symbolic and machine learning techniques

Pre-configured report models & configuration

In-text table creation and narrative generation from data analysis provides greater flexibility and control

High quality first drafts of Preclinical Reports

At Yseop, we understand the ever-evolving regulatory requirements across preclinical scientific writing. With writers facing mounting deadlines and pressure to deliver multiple studies across a growing number of molecules in the drug discovery pipeline, Yseop Copilot accelerates the delivery of drugs to market, reducing costs and impacting lives.  

Yseop Copilot was designed to automate the critical chain of preclinical documents required as part of the drug lifecycle. Each automation pack:

  • Automates content generation for preclinical scientific writing requirements
  • Eliminates excessive review cycles by removing the risk of human error in reporting
  • Creates ontologies, pre-configured report models, tables, and analysis capability to deliver highly accurate narratives

Automation packs for the pharmacokinetic, pharmacodynamic and toxicology reports augment the delivery of regulatory documents. Simply start the process with the import of the protocol and preclinical study data, and the automation packs utilize symbolic and machine learning techniques to create a high-quality first draft. 

The benefits of deep learning models

Impact: additional productivity gain + disruption in TTM gain due to full workflow automation

Life Sciences
Firms are Leading
AI Maturity

quote icon.
We wanted to be certain and very accurate around what we produce in these documents that are submitted to health authorities. We want to deliver a draft through Artificial Intelligence that is 100% reliable and needs no further editing by human medical writers. That is what we have achieved with the Yseop collaboration.
Laetitia MarosseroDomain Lead and Wearables, Sanofi
Machine learning is a part of every aspect of Lilly’s future, from drug discovery to clinical trials to manufacturing to patient support. Yseop brings a novel approach to regulatory submissions and other reporting, and we see opportunities to bring Yseop’s technology to teams throughout the enterprise.
Diogo RauSenior VP & Chief Information and Digital Officer, Lilly
Equipped with instant insights and impactful visuals and texts, our finance teams can now jump into the next generation of data analytics.
Hélène DoréGlobal Chief Transformation Officer for Finance & Legal, L'Oréal
Yseop enables us to focus our discussions on action plans for the branch. Now we spend more time talking about sales performance rather than analyzing figures. It saves time for myself and my team.
Branch DirectorFrench Multinational Retail Bank
The Yseop engine produces this commentary in less than a second. We are just scratching the surface with this technology.
Director, Global Process OwnerProduct Control at a Tier 1 US Bank
With Yseop, we give clear explanations to our customers. The customer understands the decision and I have more time to focus on other opportunities. It's a real innovation!
Client BrokerInternational Insurance Company
Previous
Next
quote icon.

Case Studies

At the forefront of innovations and developments in AI and NLG.

Lill

The Road to an Automated Clinical Document Landscape at Eli Lilly

How Lilly tapped into Generative AI capabilities with Yseop. Yseop is leading the way in content automation for regulated industries.

Generalizing business analysis access at Sanofi

Providing a summarized and dynamic sales analysis to business analysts and other key stakeholders at Sanofi.

Producing sales performance reviews at a French multinational retail bank

Providing a leading retail bank’s branch management with key performance insights and personalized action plans.
View More Case Studies

Frequently Asked Questions

Life Sciences: Preclinical

Generative AI is a class of AI techniques that involve creating content, data, or output that is not directly copied from existing examples, but rather generated by the AI system itself from data and documents.

Yseop uses generative AI for content creation in regulated industries like life science and finance. We use several types of generative AI technologies and techniques depending on the type of information used as an input and the target output format (e.g. table, text, etc.)

ChatGPT is a tool designed for consumers to test the abilities of LLMs on a wide variety of tasks and is an attempt at AGI (Artificial General Intelligence).

Yseop Copilot uses the same underlying technology (probabilistic machine learning models) in a way that meets the trust and security needs of life sciences companies.

Natural Language Generation (NLG) is a subsection of Natural Language Processing (“NLP”). NLG software turns structured data into written narratives, writing like a human being but at the speed of thousands of pages per second.

No. Yseop Copilot is meant to act as a tool to empower users to be more innovative and analytical, while automating structured, repetitive processes and calculations.

Yseop Copilot offers a platform that can automate different documents. Those documents are handled by a specific automation pack. Automation packs consist of packaged components and configurations specific to a use case or document. This affords you the freedom to select the precise automation pack that aligns perfectly with your unique requirements, granting you a solution that’s as adaptable as it is efficient.

Currently, we offer automation packs for a variety of use cases including clinical study reports, clinical trial narratives, corporate finance, credit risk, and much more.

Yes! If you are interested in learning more about Yseop’s content automation solutions, we encourage you to sign up for a free trial to see the technology work in action.

Clinical study reports, clinical trial narratives, summary clinical safety, and preclinical study reports for pharmacokinetics.

Yes. Yseop Copilot is 100% accurate based on the input of information into the platform. However, it is meant to be a first draft for writers to go in and finalize based on style and writing preferences.

Still have questions?

ASK AN EXPERT

Talk to One of Our Experts

Let’s start automating your data to narratives today!

Scroll to Top